• Our Research
    • Translation
    • Labs
    • Projects
    • Researchers
    • Publications
    • News
    • CoreNews
    • Events
    • Symposium
    • LISA Summer Academy
    • Mission & Values
    • Management
    • Advisory & Supervisory Board
    • Alumni
Simple Language
deen
  1. People
  2. Dr. Patrick Behrendt
  3. Publications

Publications

2025Nature Communications16 (1) : 1995

Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice

Ssebyatika G, Dinkelborg K, Ströh L, Hinte F, Corneillie L, Hueffner L, Guzman E, Nankya P, Plückebaum N, Fehlau L, Garn J, Meyer N, Prallet S, Mehnert A, Kraft A, Verhoye L, Jacobsen C, Steinmann E, Wedemeyer H, Viejo-Borbolla A, Dao Thi V, Pietschmann T, Lütgehetmann M, Meuleman P, Dandri M, Krey T, Behrendt P

More Information PubMed
2024Nature Communications15 (1) : 4855

Genetic determinants of host- and virus-derived insertions for hepatitis E virus replication

Wißing M, Meister T, Nocke M, Gömer A, Masovic M, Knegendorf L, Brüggemann Y, Bader V, Siddharta A, Bock C, Ploss A, Kenney S, Winklhofer K, Behrendt P, Wedemeyer H, Steinmann E, Todt D

More Information PubMed
2024One Health (amsterdam, Netherlands)18 : 100674

Immunisation of pigs with recombinant HEV vaccines does not protect from infection with HEV genotype 3

Dähnert L, Aliabadi E, Fast C, Hrabal I, Schröder C, Behrendt P, Protzer U, Groschup M, Eiden M

More Information PubMed
2024Jhep Reports : Innovation in Hepatology6 (3) : 100989

Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment

Gömer A, Dinkelborg K, Klöhn M, Jagst M, Wißing M, Frericks N, Nörenberg P, Behrendt P, Cornberg M, Wedemeyer H, Steinmann E, Maasoumy B, Todt D

More Information PubMed
2023Emerging Microbes & Infections12 (2) : 2251598

Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing

Stahl Y, Kabar I, Heinzow H, Maasoumy B, Bremer B, Wedemeyer H, Schmidt H, Pietschmann T, Schlevogt B, Behrendt P

More Information PubMed
2023Hepatology (baltimore, Md.)78 (6) : 1882-1895

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients

Gömer A, Klöhn M, Jagst M, Nocke M, Pischke S, Horvatits T, Schulze Zur Wiesch J, Müller T, Hardtke S, Cornberg M, Wedemeyer H, Behrendt P, Steinmann E, Todt D

More Information PubMed
2023Antiviral Research217 : 105690

Janus kinase-inhibition modulates hepatitis E virus infection

Kinast V, Andreica I, Ahrenstorf G, Gömer A, Elsner C, Schlienkamp S, Schrader J, Klöhn M, Ulrich R, Broering R, Vondran F, Todt D, Behrendt P, Dittmer U, Hamprecht A, Witte T, Baraliakos X, Steinmann E

More Information PubMed
2023Hepatology (baltimore, Md.)77 (6) : 2104-2117

EGF receptor modulates HEV entry in human hepatocytes

Schrader J, Burkard T, Brüggemann Y, Gömer A, Meister T, Fu R, Mehnert A, Dao Thi V, Behrendt P, Durantel D, Broering R, Vondran F, Todt D, Kinast V, Steinmann E

More Information PubMed
2023Hepatology (baltimore, Md.)77 (5) : 1475-1477

Urine: a place where HEV cannot hide!

Behrendt P, Gouttenoire J

More Information PubMed
2023Alimentary Pharmacology & Therapeutics57 (1) : 136-145

Application of CT contrast medium is not associated with an increased risk for acute kidney injury in patients with decompensated cirrhosis

Tergast T, Schulte B, Griemsmann M, Kahlhöfer J, Dörge P, Hinrichs J, Kraft A, Schmidt J, Behrendt P, Wedemeyer H, Cornberg M, Maasoumy B

More Information PubMed
1 2
...
5
deen

TWINCORE
Zentrum für Experimentelle und Klinische Infektionsforschung GmbH
Feodor-Lynen-Str. 7
30625 Hannover

TWINCORE is a joint institution of:
ImprintPrivacy PolicyAccessibility